EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration

Jiayan Wei, Jinsong Wang, Xinyi Chen, Li Zhang, Min Peng

PeerJ · 2024

DOI: 10.7717/peerj.16819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Jiayan Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Ferroptosis, Liver Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation of China, The Hubei Science Foundation for Distinguished Young Scholars, The Interdisciplinary Innovative Talents Foundation from Renmin Hospital of Wuhan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) stands as the prevailing manifestation of primary liver cancer and continues to pose a formidable challenge to human well-being and longevity, owing to its elevated incidence and mortality rates. Nevertheless, the quest for reliable predictive biomarkers for HCC remains ongoing. Recent research has demonstrated a close correlation between ferroptosis and disulfidptosis, two cellular processes, and cancer prognosis, suggesting their potential as predictive factors for HCC. In this study, we employed a combination of bioinformatics algorithms and machine learning techniques, leveraging RNA sequencing data, mutation profiles, and clinical data from HCC samples in The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and the International Cancer Genome Consortium (ICGC) databases, to develop a risk prognosis model based on genes associated with ferroptosis and disulfidptosis. We conducted an unsupervised clustering analysis, calculating a risk score (RS) to predict the prognosis of HCC using these genes. Clustering analysis revealed two distinct HCC clusters, each characterized by significantly different prognostic and immune features. The median RS stratified HCC samples in the TCGA, GEO, and ICGC cohorts into high-and low-risk groups. Importantly, RS emerged as an independent prognostic factor in all three cohorts, with the high-risk group demonstrating poorer prognosis and a more active immunosuppressive microenvironment. Additionally, the high-risk group exhibited higher expression levels of tumor mutation burden (TMB), immune checkpoints (ICs), and human leukocyte antigen (HLA), suggesting a heightened responsiveness to immunotherapy. A cancer stem cell infiltration analysis revealed a higher similarity between tumor cells and stem cells in the high-risk group. Furthermore, drug sensitivity analysis highlighted significant differences in response to antitumor drugs between the two risk groups. In summary, our risk prognostic model, constructed based on ferroptosis-related genes associated with disulfidptosis, effectively predicts HCC prognosis. These findings hold potential implications for patient stratification and clinical decision-making, offering valuable theoretical insights in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularFerroptosisLiver NeoplasmsHumansAlgorithmsClinical Decision-MakingTumor Microenvironment

Stichwörter der Autor:innen

DisulfidptosisFerroptosisHCCPrognosis modelTumor microenvironment

Autor:innen und Institutionen

  • Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
  • Basic Medical Sciences, Wuhan University School of Basic Medical Sciences, Wuhan, Hubei, China.

Förderung

  • National Science Foundation of China
  • The Hubei Science Foundation for Distinguished Young Scholars
  • The Interdisciplinary Innovative Talents Foundation from Renmin Hospital of Wuhan University
  • Beijing Science and Innovation Medical Development Foundation
  • China primary healthcare foundation
  • China Zhongguancun Precision Medicine Science and Technology Foundation
  • Hubei Science Foundation for Distinguished Young Scholars
  • Interdisciplinary Innovative Talents Foundation from Renmin Hospital of Wuhan University

Zitieren

APA

Wei, J., Wang, J., Chen, X., Zhang, L., & Peng, M. (2024). Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration. PeerJ. https://doi.org/10.7717/peerj.16819

Vancouver

Wei J, Wang J, Chen X, Zhang L, Peng M. Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration. PeerJ. 2024. doi:10.7717/peerj.16819

BibTeX
@article{Wei2024,
  author = {Wei, Jiayan and Wang, Jinsong and Chen, Xinyi and Zhang, Li and Peng, Min},
  title = {Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.16819}
}
Kostenlos starten →